BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 25409409)

  • 1. [Hypertension and diabetes: target blood pressure and blood pressure lowering by new antidiabetic drugs].
    Kintscher U; Jacob S
    Dtsch Med Wochenschr; 2014 Nov; 139(48):2468-9. PubMed ID: 25409409
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood pressure effects of glucagon-like peptide 1 analogues and sodium glucose transporter 2 inhibitors.
    Engeli S; Jordan J
    Curr Opin Nephrol Hypertens; 2014 Sep; 23(5):468-72. PubMed ID: 24914567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of hypertension in patients with type 2 diabetes mellitus].
    Hess K
    Dtsch Med Wochenschr; 2012 Nov; 137(48):2489-92. PubMed ID: 23114910
    [No Abstract]   [Full Text] [Related]  

  • 4. The goal blood pressure in type 2 diabetes: do we have an ACCORD?
    Crouch MA
    Consult Pharm; 2010 Oct; 25(10):686, 688. PubMed ID: 21030359
    [No Abstract]   [Full Text] [Related]  

  • 5. Trial watch: SGLT2 inhibitor shows promise in type 2 diabetes.
    Nat Rev Drug Discov; 2010 Mar; 9(3):182. PubMed ID: 20190779
    [No Abstract]   [Full Text] [Related]  

  • 6. Care of type 2 diabetes: where do the new medications fit?
    Clem CO; Heins JR
    S D Med; 2015 Mar; 68(3):126-7. PubMed ID: 25906502
    [No Abstract]   [Full Text] [Related]  

  • 7. [Medications for type-2 diabetes and high blood pressure].
    Schröder H
    Med Monatsschr Pharm; 2002 Nov; 25(11):386-8. PubMed ID: 12474347
    [No Abstract]   [Full Text] [Related]  

  • 8. Rationale and design of the AdRem study: evaluating the effects of blood pressure lowering and intensive glucose control on vascular retinal disorders in patients with type 2 diabetes mellitus.
    Chaturvedi N; Bilous R; Sjolie AK; Klein R;
    Contemp Clin Trials; 2007 Nov; 28(6):780. PubMed ID: 17643353
    [No Abstract]   [Full Text] [Related]  

  • 9. [54-year-old patient with type 2 diabetes mellitus and increased blood pressure values].
    Hartsleben ChH; Battegay E
    Praxis (Bern 1994); 2005 Mar; 94(11):433-5. PubMed ID: 15822441
    [No Abstract]   [Full Text] [Related]  

  • 10. Blood pressure-lowering effects of GLP-1 receptor agonists exenatide and liraglutide: a meta-analysis of clinical trials.
    Wang B; Zhong J; Lin H; Zhao Z; Yan Z; He H; Ni Y; Liu D; Zhu Z
    Diabetes Obes Metab; 2013 Aug; 15(8):737-49. PubMed ID: 23433305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Type 2 diabetic patients with hypertension: do they prefer treating diabetes or hypertension?].
    El Aassri H; El Mghari G; El Ansari N
    Pan Afr Med J; 2014; 17():193. PubMed ID: 25396019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial dysfunction and hypertension in diabetes mellitus.
    Dandona P; Chaudhuri A; Aljada A
    Med Clin North Am; 2004 Jul; 88(4):911-31, x-xi. PubMed ID: 15308385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Guidelines for the treatment of arterial hypertension in diabetes mellitus. The consensus recommendations of the German League for the Fight against High Blood Pressure, Inc., the German Diabetes Society and the Society for Nephrology].
    Schäfers RF; Lütkes P; Ritz E; Philipp T
    Dtsch Med Wochenschr; 1999 Nov; 124(45):1356-72. PubMed ID: 10592780
    [No Abstract]   [Full Text] [Related]  

  • 14. Randomized clinical trials: prescriptions to be applied with caution!
    Alderman MH
    Am J Hypertens; 2008 May; 21(5):483-4. PubMed ID: 18437132
    [No Abstract]   [Full Text] [Related]  

  • 15. Antidiabetic Drugs as Antihypertensives: New Data on the Horizon.
    Mamakou V; Eleftheriadou I; Katsiki N; Makrilakis K; Tsioufis K; Tentolouris N
    Curr Vasc Pharmacol; 2017; 16(1):70-78. PubMed ID: 29032756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel role for the incretins in blood pressure regulation.
    Yerram P; Whaley-Connell A
    Curr Opin Nephrol Hypertens; 2012 Sep; 21(5):463-8. PubMed ID: 22871675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular and renal benefits are additive using intensive blood pressure control and incremental glucose control in type 2 diabetic patients.
    Cardiovasc J Afr; 2008; 19(5):284-6. PubMed ID: 18997995
    [No Abstract]   [Full Text] [Related]  

  • 18. Medication adherence affects treatment modifications in patients with type 2 diabetes.
    Voorham J; Haaijer-Ruskamp FM; Wolffenbuttel BH; Stolk RP; Denig P;
    Clin Ther; 2011 Jan; 33(1):121-34. PubMed ID: 21397778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Trends in subclinical atherosclerosis in patients with arterial hypertension associated with diabetes mellitus: a relationship between blood pressure achieved with antihypertensive therapy and body weight].
    Karpov RS; Koshel'skaia OA; Khoroshilova IV
    Ter Arkh; 2010; 82(9):23-30. PubMed ID: 21086616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of exenatide on systolic blood pressure in subjects with type 2 diabetes.
    Okerson T; Yan P; Stonehouse A; Brodows R
    Am J Hypertens; 2010 Mar; 23(3):334-9. PubMed ID: 20019672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.